Concepedia

C C Bancroft

CC

Statistics

Publications

6

Citations

1.4K

H-Index

6

Active since

2000

Affiliations

National Institute on Deafness and Other Communication Disorders(Current)

National Institutes of Health

C C Bancroft is an author at National Institute on Deafness and Other Communication Disorders specializing in oncology, cancer cell signaling, and molecular oncology.

Publications per year

2000–2002

6

Publications

6

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

John B. Sunwoo, Zhong Chen, Guo‐Chung Dong et al. · PubMed · 2001 · 479 citations

, , +16

Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.

Gang Dong, Zhong Chen, Z Y Li et al. · PubMed · 2001 · 283 citations

, , +15

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines

C C Bancroft, Zhong Chen, Jason Yeh et al. · International Journal of Cancer · 2002 · 231 citations · Full text

, , +15

IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.

J. Wolf, Zhong Chen, Guo‐Chung Dong et al. · PubMed · 2001 · 215 citations

, , +15

Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.

C C Bancroft, Zhong Chen, Gang Dong et al. · PubMed · 2001 · 178 citations

, , +17

1–5 of 6